KKR has appointed the former CEO of the Tokyo Stock Exchange and the Japan Exchange Group (JPX), Atsushi Saito, as non-executive chairman of KKR Japan, the buyout firm announced in a statement. Saito will take up the post on 1 August.
Saito served as the group CEO, president and representative executive officer at JPX from 2013 until his retirement in June 2015. Prior to that, he was president and CEO of the Tokyo Exchange Group from 2007 until its merger with the Osaka Securities Exchange in 2013 to form JPX.
His previous roles also include president and CEO of the Industrial Revitalisation Corporation of Japan, a government-sponsored turnaround organisation, CEO of Sumitomo Life Investment and an executive and board member at Nomura Securities.
In June Japan’s Panasonic Healthcare Holdings Company, in which KKR holds an 80 percent stake, agreed to acquire Bayer Diabetes Care from Germany’s Bayer AG for about €1 billion, as reported by Private Equity International.
KKR bought the stake in Panasonic Healthcare in 2014 for $1.67 billion through its KKR Asian II fund that closed at $6 billion in 2013. The fund has also invested in Pioneer DJ, acquiring an 85 percent stake in 2015 from Pioneer Foundation.
KKR’s announcement of Saito’s appointment follows Permira’s announcement in mid-July that it has appointed Yoichiro Furuse as chairman of its Japan business and Ryotaro Fujii as its new managing director and head of Japan, as reported by PEI.